Dimensional Fund Advisors LP Werewolf Therapeutics, Inc. Transaction History
Dimensional Fund Advisors LP
- $405 Billion
- Q4 2024
A detailed history of Dimensional Fund Advisors LP transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 194,746 shares of HOWL stock, worth $290,171. This represents 0.0% of its overall portfolio holdings.
Number of Shares
194,746
Previous 257,844
24.47%
Holding current value
$290,171
Previous $546,000
47.25%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding HOWL
# of Institutions
75Shares Held
29.2MCall Options Held
10.7KPut Options Held
500-
Ra Capital Management, L.P. Boston, MA6.14MShares$9.16 Million0.15% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.28MShares$6.38 Million5.1% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.91MShares$4.33 Million0.28% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.39MShares$3.56 Million0.53% of portfolio
-
Bank Of America Corp Charlotte, NC2.08MShares$3.1 Million0.0% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $44M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...